PHI with Varicose veins
How does this condition affect your private health insurance?
Varicose veins are swollen, twisted veins, most commonly appearing in the legs, caused by weakened vein walls and faulty valves. This leads to inefficient blood flow back to the heart, causing blood to pool, stretching and enlarging the veins. Symptoms often include aching pain, heaviness, throbbing, muscle cramping, and swelling in the lower legs. In some cases, skin discoloration, ulcers, or bleeding can occur. Risk factors include genetics, age, prolonged standing, obesity, and pregnancy. While often benign, they can sometimes indicate more serious circulatory issues or lead to complications.
PKV Risk Assessment
Impact on Your Insurance Policy
Duration of Illness (Initial)
Symptoms often develop gradually, from several weeks to months before becoming bothersome or being diagnosed.
Duration of Illness (Lifetime)
Chronic, often lifelong condition with potential for progression or recurrence even after treatment.
Cost of Treatment (Initial)
Ranges from several hundred (e.g., sclerotherapy) to several thousand euros/dollars (e.g., laser ablation, surgery) per leg, depending on severity and method.
Cost of Treatment (Lifetime)
Can range from low for conservative management to tens of thousands of euros/dollars for multiple interventions over a lifetime.
Mortality Rate
Extremely low; death is typically associated with very rare and severe complications like deep vein thrombosis (DVT) leading to pulmonary embolism.
Risk of Secondary Damages
Moderate to high, including skin changes (eczema, hyperpigmentation), lipodermatosclerosis, venous ulcers, superficial thrombophlebitis, and bleeding; psychological impact is also possible.
Probability of Full Recovery
High for the treated veins, meaning symptoms resolve and affected veins are eliminated. However, the underlying predisposition can lead to new varicose veins forming over time.
Underlying Disease Risk
Low for other acute underlying diseases causing varicose veins. However, varicose veins are a primary manifestation of chronic venous insufficiency, and genetic predisposition is a significant factor.